Sun Pharma Announces Licensing Agreement With CSIR-IICT
This collaboration with CSIR-IICT for developing new drugs is part of our broader strategy for enhancing our global specialty…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dilip Shanghvi
Sun Pharma announces positive results of two phase-III CTs of Tildrakizumab
The IL-23p19 Therapeutic Antibody meets primary endpoints in both placebo-controlled studies and secondary endpoint in…
‘DRILS Synergy 2015’ symposium organised
The programme saw industry leaders and academia under one roof to discuss opportunities to build a culture of innovation and…
Sun Pharma posts net profit of Rs 479 crores Q1FY16
Net sales has been registered at Rs 6,522 crores
Sun Pharmaceutical Industries has posted its financials for first quarter ending…
SAC-ACCP organises eighth annual international conference
Felicitates six industry stakeholders and institutions
South Asian Chapter of American College of Clinical Pharmacology…
Sun Pharma announces closure of merger deal with Ranbaxy
The combined entity’s manufacturing footprint covers five continents with products sold in over 150 nations
CCI approves Ranbaxy acquisition by Sun Pharma
Sun Pharma and Ranbaxy had filed the notice with the CCI on May 6, 2014 and sought its approval with respect to the deal